PathogenDx's breakthrough technology shifts the pathogen detection paradigm from microbial to molecular testing through its microarray assays, namely DetectX, EnviroX, and QuantX SANTA CLARA, ...
EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ — AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® Celiac Disease ...
All reagents and multiplex microarray magazines are equipped with RFID tags to save time while avoiding manual errors. Unique combination of tests The MosaiQ AiPlex CTDplus assay enables a syndromic ...
MiRNA microarray kits and reagents market is experiencing robust growth driven by rising demand for precision diagnostics, biomarker discovery, and translational research. Expansion of oncology ...
Multiplexing technologies are essential for the rapid screening of large numbers of samples in proteomic and genomic profiling. Tool providers are increasingly offering new solutions that feature ...
(*𝐍𝐎𝐓𝐄: 𝐓𝐨 𝐠𝐞𝐭 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐭𝐨 𝐲𝐨𝐮𝐫 𝐥𝐢𝐤𝐢𝐧𝐠 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐀𝐃𝐃 / 𝐑𝐄𝐌𝐎𝐕𝐄 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 ...
The MosaiQ AiPlex CD is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows The MosaiQ AiPlex CD multiplex assay, which received IVDR-CE mark ...
MiRNA microarray kits and reagents market is experiencing robust growth driven by rising demand for precision diagnostics, biomarker discovery, and translational research. Expansion of oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback